Skip to content
Screener

Perrigo Company PRGO Q4 2025 Annual earnings

Reported February 26, 2026 · Before market open

Revenue$1.1BBeat by $7.7M
EPS$0.77Miss by $0.03
Revenue estimate$1.1B
EPS estimate$0.80

Next report

Nov 4, 2026 (in 2 months)
Revenue estimate$991.5M
EPS estimate$0.52

Financials

Q4 2025

Income statement

See full
Revenue$1.1B-2.5%
Gross profit$362.2M-6.1%
Operating income-$1.3B-1,227%
Net income-$1.4B-3,087%
EPS (diluted)-$10.24-3,100%

Balance sheet

See full
Cash & equivalents$531.6M-4.9%
Total debt$3.9B+0.5%
Total equity$2.9B-32.0%
Total assets$8.5B-11.5%

Cash flow

See full
Operating cash flow$175.4M-43.9%
CapEx$26.8M-28.9%
Free cash flow$148.6M-45.9%

Valuation & ratios

Valuation

as of 12/31/25
See full
Market cap$1.92B-45.4%
Enterprise value$5.25B-22.8%
P/S0.5×-0.4×

Profitability

See full
Gross margin35.1%-0.1pp
Operating margin-26.4%-29.0pp
Net margin-33.5%-38.6pp

Returns & leverage

See full
Return on equity-39.3%-44.0pp
Debt / equity1.3×+0.4×
Current ratio2.8×+0.4×

Segments

By product

See full
Upper Respiratory$217.8M+5.5%
Healthy Lifestyle$146.2M+7.4%
Digestive Health$134.0M-7.7%
Oral Care$88.6M-5.4%
Women's Health$59.9M+18.1%

FAQ

When did Perrigo Company report Q4 2025 earnings?
Perrigo Company (PRGO) reported Q4 2025 earnings on February 26, 2026 before market open.
What were Perrigo Company's Q4 2025 revenue and EPS?
Perrigo Company reported revenue of $1.1B and eps of $0.77 for Q4 2025.
Did Perrigo Company beat estimates in Q4 2025?
Revenue beat the consensus estimate of $1.1B by $7.7M. EPS missed the consensus estimate of $0.80 by $0.03.
How did Perrigo Company's Q4 2025 results compare year-over-year?
Compared to the same quarter a year prior, revenue declined 2.5% from $1.1B a year earlier and eps declined 17.2% from $0.93.
Where can I find Perrigo Company's Q4 2025 SEC filings?
You can read the 8-K earnings release (0001585364-26-000006) and the 10-K periodic report (0001585364-26-000009) directly on SEC EDGAR. The filing index links above go to sec.gov.